Jing Liu
liu_jing@gibh.ac.cn
Chinese, English
Guangdong
University of Chinese Academy of Sciences
Medical School
  • 2009-09--2012-06 Ph.D. in Science: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
  • 2007-09--2009-08 M.Sc. in Science: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
  • 2003-09--2007-06 B.Sc. in Science: Hubei University
  • 2018-01~Present - Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences - Researcher
  • 2013-01~2017-12 - Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences - Associate Researcher
  • 2012-07~2012-12 - Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences - Assistant Researcher
  • Outstanding Scientific Achievement Award, Chinese Academy of Sciences (2017)
  • First Prize in MET Research in iPS Cell Induction (2014)
Cell Fate Regulation and Systems Biology
Stem Cells and Chemical Biology
Epigenetics
Disease Models and Organ Reconstruction
Mathematical Modeling of Biological Processes
  • Epigenetic reshaping through damage: promoting cell fate transition by BrdU and IdU incorporation, Jing Liu, 2024
  • H3K27ac mediated SS18/BAFs relocation regulates JUN induced pluripotent-somatic transition, Jing Liu, 2022
  • Static Magnetic Fields Regulate T-Type Calcium Ion Channels and Mediate Mesenchymal Stem Cells Proliferation, Jing Liu, 2022
  • BMP4 drives primed to naïve transition through PGC-like state, Jing Liu, 2022
  • CRISPR/Cas9-Mediated Suds3 Knockout Inhibited Mouse Embryonic Stem Cell Proliferation and Mesoderm/Endoderm Differentiation, Jing Liu, 2021
  • Forkhead box family transcription factors as versatile regulators for cellular reprogramming to pluripotency, Jing Liu, 2021
  • ScGSLC: An unsupervised graph similarity learning framework for single-cell RNA-seq data clustering, Jing Liu, 2021
  • AP-1 activity is a major barrier of human somatic cell reprogramming, Jing Liu, 2021
  • The nuclear factor CECR2 promotes somatic cell reprogramming by reorganizing the chromatin structure, Jing Liu, 2021
  • SS18 regulates pluripotent-somatic transition through phase separation, Jing Liu, 2021
  • BMP4 resets mouse epiblast stem cells to naive pluripotency through ZBTB7A/B-mediated chromatin remodelling, Jing Liu, 2020
  • A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic Cancer, Jing Liu, 2020
  • Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Jdp2-Jhdm1b-Mkk6-Glis1-Nanog-Essrb-Sall4, Jing Liu, 2019
  • Resolving Cell Fate Decisions during Somatic Cell Reprogramming by Single-Cell RNA-Seq, Jing Liu, 2019
  • Chromatin Accessibility Dynamics during Chemical Induction of Pluripotency, Jing Liu, 2019
  • Mettl17, a regulator of mitochondrial ribosomal RNA modifications, is required for the translation of mitochondrial coding genes, Jing Liu, 2019
  • Chromatin Accessibility Dynamics during Chemical Induction of Pluripotency, Jing Liu, 2018
  • Chromatin Accessibility Dynamics during iPSC Reprogramming, Jing Liu, 2017
  • Chemical reprogramming of mouse embryonic and adult fibroblast into endoderm lineage, Jing Liu, 2017
  • Kdm2b Regulates Somatic Reprogramming through Variant PRC1 Complex-Dependent Function, Jing Liu, 2017
  • Perspective of stem cell and regenerative medicine, Jing Liu, 2016
  • Cyclin-dependent Kinase-mediated Sox2 Phosphorylation Enhances the Ability of Sox2 to Establish the Pluripotent State, Jing Liu, 2015
  • The oncogene c-Jun impedes somatic cell reprogramming, Jing Liu, 2015
  • Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming, Jing Liu, 2013
  • H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs, Jing Liu, 2013
  • Optimization and Mechanism Study of Induced Reprogramming Culture System, Jing Liu, 2012
  • BMPs functionally replace KLf4, and support efficient reprogramming of mouse fibroblasts by Oct4 alone, Jing Liu, 2011
  • Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics, Jing Liu, 2011
  • Reprogramming of mouse and human somatic cells by high-performance engineered factors, Jing Liu, 2011
  • Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells, Jing Liu, 2011
  • Towards an Optimized Culture Medium for the Generation of Mouse Induced Pluripotent Stem Cells, Jing Liu, 2010
Cell Fate Systems Biology Stem Cells Chemical Biology Epigenetics Disease Models Organ Reconstruction Mathematical Modeling Biological Processes Regulation

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.